Kit comprising antihuman TNF-α antibody and antihuman...

Details Kit comprising antihuman TNF-α antibody and antihuman... Kit comprising antihuman TNF-α antibody and antihuman...

2006-09-01

2009-12-29

Landsman, Robert (Department: 1647)

Chemistry: molecular biology and microbiology

Kit

C435S810000, C424S400000

Reexamination Certificate

active

07638335

ABSTRACT:
The present invention provides an antihuman TNF-α antibody activity lowering inhibitor comprising a protein source(s) and/or carbohydrate source(s), in the treatment of inflammatory bowel syndrome with repeated administration of anti-TNF-α antibody; and a kit preparation wherein a freeze-dried antihuman TNF-α antibody and the activity lowering inhibitor in the above repeated administration of the anti-TNF-α antibody are separately contained in a plastic container so that they can communicate with each other. According to the present invention, in the drug therapy to the patients with inflammatory bowel syndrome, therapeutic agents which inhibit the inflammation for long periods without accompanying serious side effects can be provided.

REFERENCES:
patent: 5656272 (1997-08-01), Le et al.
patent: 5698195 (1997-12-01), Le et al.
patent: 5741488 (1998-04-01), Feldman et al.
patent: 5919452 (1999-07-01), Le et al.
patent: 6277969 (2001-08-01), Le et al.
patent: 6284471 (2001-09-01), Le et al.
patent: 6790444 (2004-09-01), Le et al.
patent: 6835823 (2004-12-01), Le et al.
patent: 6991791 (2006-01-01), Le et al.
patent: 2001/0027249 (2001-10-01), Le et al.
patent: 2002/0022720 (2002-02-01), Le et al.
patent: 2002/0114805 (2002-08-01), Le et al.
patent: 2002/0141996 (2002-10-01), Le et al.
patent: 2002/0146419 (2002-10-01), Le et al.
patent: 2003/0017584 (2003-01-01), Le et al.
patent: 2003/0054004 (2003-03-01), Le et al.
patent: 2003/0064040 (2003-04-01), Lukacsko
patent: 2003/0133935 (2003-07-01), Le et al.
patent: 2003/0144484 (2003-07-01), Le et al.
patent: 2003/0147891 (2003-08-01), Le et al.
patent: 2003/0175275 (2003-09-01), Le et al.
patent: 2003/0175837 (2003-09-01), Le et al.
patent: 2003/0176676 (2003-09-01), Le et al.
patent: 2003/0180299 (2003-09-01), Le et al.
patent: 2003/0181695 (2003-09-01), Le et al.
patent: 2003/0187231 (2003-10-01), Le et al.
patent: 2003/0194402 (2003-10-01), Le et al.
patent: 2003/0198634 (2003-10-01), Le et al.
patent: 2003/0198641 (2003-10-01), Le et al.
patent: 2003/0204066 (2003-10-01), Le et al.
patent: 2004/0115200 (2004-06-01), Le et al.
patent: 2004/0138427 (2004-07-01), Le et al.
patent: 2005/0037008 (2005-02-01), Le et al.
patent: 2005/0074454 (2005-04-01), Le et al.
patent: 2006/0013816 (2006-01-01), Le et al.
patent: 2006/0018905 (2006-01-01), Le et al.
patent: 2006/0018906 (2006-01-01), Le et al.
patent: 2006/0024310 (2006-02-01), Le et al.
patent: 2006/0211631 (2006-09-01), Mitsumoto et al.
patent: 0 689 835 (1996-01-01), None
patent: 8-73351 (1996-03-01), None
patent: 8-505365 (1996-06-01), None
patent: 11-503752 (1999-03-01), None
patent: 92/16553 (1992-10-01), None
patent: 94/08619 (1994-04-01), None
Nomura M, et al. Nippon shokakibyo Gakkai Zasshi, 92(1), Abstract, Jan. 1995.
Sanders TA, American J. Clinical Nutrition, 71(Suppl 1), Abstract, Jan. 2000.
Present, et al., “Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease,” The New England Journal of Medicine, vol. 340, No. 18, May 6, 1999, pp. 1398-1405.

Affiliated with

Also associated with

Rating

Kit comprising antihuman TNF-α antibody and antihuman... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kit comprising antihuman TNF-α antibody and antihuman..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kit comprising antihuman TNF-α antibody and antihuman... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4137492